Woodcock Becomes PCORI Board's First FDA Representative

Center for Drug Evaluation and Research director accepts six-year term on Board of Governors of the Patient-Centered Outcomes Research Institute, which funds comparative effectiveness studies.

Binocular viewer_1200X675

More from Clinical Trials

More from R&D